For example, in CML, BCL6 upregulation by kinase inhibitors has been shown to be facilitated by interferon-gamma-induced STAT1 activation [126] and the relief of STAT5-mediated BCL6 gene repression [118]. Here, BCL6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.